6-bromoundecane | 106593-84-4

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机溴化物
• 英文名称: 6-bromoundecane
• CAS: 106593-84-4
• 化学式: C₁₁H₂₃Br
• 分子量: 235.208
• InChiKey: LXAKVLBCNLKTKI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  12
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  6-bromoundecane 在 乙醚 、 sodium 作用下， 生成 6,7-dipentyl-dodecane
  参考文献：
  名称：

  Petrow; Kaplan, Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1949, p. 539,544

  摘要：

  DOI：
• 作为产物：
  描述：

  6-十一烷醇 在 三溴化磷 作用下， 生成 6-bromoundecane
  参考文献：
  名称：

  Petrow; Kaplan, Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1949, p. 539,544

  摘要：

  DOI：

文献信息

• Hunsdiecker-Type Bromodecarboxylation of Carboxylic Acids with Iodosobenzene Diacetate–Bromine
  作者：Pelayo Camps、Andrés E Lukach、Xavier Pujol、Santiago Vázquez

  DOI：10.1016/s0040-4020(00)00169-1

  日期：2000.4

  Carboxylic acids are bromodecarboxylated in moderate to good yields on reaction with iodosobenzene diacetate and bromine under irradiation with a tungsten lamp. The reaction works very well with carboxylic acids having a primary, secondary or tertiary α-carbon atom, although diphenylacetic acid gives benzophenone. Benzoic acid derivatives are bromodecarboxylated in moderate yields if electron-withdrawing

  在用钨灯照射下，与碘代苯二乙酸酯和溴反应后，羧酸以中等到良好的产率被溴代羧化。该反应对于具有伯，仲或叔α-碳原子的羧酸非常有效，尽管二苯乙酸生成了二苯甲酮。如果在苯环中存在吸电子取代基，则苯甲酸衍生物会以中等产率被溴代羧化，而如果取代基是给电子体，则苯甲酸衍生物的回收率基本保持不变。已经从具有两个桥头α-碳原子的二羧酸的双溴代双羧化反应中以低收率分离出部分碘化的产物。
• Thiazolo[4,5-<i>d</i>]pyrimidines. Part I. synthesis and anti-human cytomegalovirus (HCMV) activity<i>in vitro</i>of certain alkyl derivatives
  作者：Arthur F. Lewis、Ganapathi R. Revankar、Susan M. Fennewald、Robert F. Rando、John H. Huffman

  DOI：10.1002/jhet.5570320230

  日期：1995.3

  Alkyl derivatives of the thiazolo[4,5-d]pyrimidine congeners of guanine and uracil were prepared and assessed for in vitro activity against human cytomegalovirus (HCMV). The finding that the 3-pentyl 1b and 3-hexyl 1c derivatives of 5-aminothiazolo[4,5-d]pyrimidine-2,7(3H,6H)-dione (1e) had potent in vitro anti-HCMV activity prompted a broader study of alkyl derivatives in this ring system. A series

  制备鸟嘌呤和尿嘧啶的噻唑并[4，5- d ]嘧啶同类物的烷基衍生物，并评估其对人巨细胞病毒（HCMV）的体外活性。5-氨基噻唑并[4,5- d ]嘧啶-2,7（3 H，6 H）-二酮（1e）的3-戊基1b和3-己基1c衍生物具有很强的体外抗HCMV活性的发现促使对该环系统中的烷基衍生物进行更广泛的研究。1e的一系列3-烷基衍生物，即。通过将1e的钠盐直接烷基化制备1f-w 以及随后的修改2a-d。为了与1c进行比较，制备并研究了5-氨基-2-己基氨基噻唑并[4，5- d ]嘧啶-7（6H）-一（4）。发现1e的3-（2-链烯基）衍生物是具有更强活性的抗病毒药，具有5-氨基-3-（2-戊烯-1-基）噻唑并[4,5- d ]嘧啶-的Z异构体。2,7（3 H，6 H）-二酮（1f）具有更好的治疗指数。2-氨基噻唑并[4,5 - d ]嘧啶-5,7（4 H，6 H）-二酮6a和6b的类似4-（2-
• Antiviral guanine analogs
  申请人：Aronex Pharmaceuticals, Inc.

  公开号：US05994321A1

  公开（公告）日：1999-11-30

  A series of guanine analogs and physiological salts thereof, which are useful as virus inhibitors and as antiviral agents in the treatment of viral disease, having the basic structures of: ##STR1## wherein B is H, CH.sub.3 or NH.sub.2 ; C is NH.sub.2 or SCH.sub.3 ; D is N or CH; E is O, S or Se; and G is selected from a group consisting of alkanes, alkenes, ethers, esters, hydrocarbons, amines and heterocyclic compounds, is herein disclosed. In I and III, A is O, S or Se while in II, A is NH.sub.2, OH, NHOH, OCH.sub.3 or SCH.sub.3. In I and II, F is 0, S or Se, while in III, F is F is 0, S, Se or NH. These compounds may be formulated with a physiological carrier, and used either alone or in combination with, for example, acyclovir or ganciclovir or another therapeutic agent, for the treatment of conditions resulting from viral infections.

  一系列鸟嘌呤类似物及其生理盐，可用作病毒抑制剂和抗病毒剂，用于治疗病毒性疾病，具有以下基本结构：##STR1## 其中B为H、CH.sub.3或NH.sub.2；C为NH.sub.2或SCH.sub.3；D为N或CH；E为O、S或Se；G选自烷烃、烯烃、醚、酯、碳氢化合物、胺和杂环化合物组成的一组。在I和III中，A为O、S或Se，而在II中，A为NH.sub.2、OH、NHOH、OCH.sub.3或SCH.sub.3。在I和II中，F为O、S或Se，而在III中，F为O、S、Se或NH。这些化合物可以与生理载体配制，并单独使用或与阿昔洛韦或甘氟韦等其他治疗剂联合使用，用于治疗病毒感染引起的疾病。
• 4,6-DI-t-BUTYL-2,3-DIHYDROBENZOTHIOPHENES WHICH INHIBIT LDL OXIDATION
  申请人：CHUGAI SEIYAKU KABUSHIKI KAISHA

  公开号：EP0791589A1

  公开（公告）日：1997-08-27

  A compound represented by formula (I): wherein R1 represents a hydrogen atom, a lower alkyl group or an acyl group; R2 and R3, which may be the same or different, each represents a hydrogen atom, an optionally substituted alkyl group, or an optionally substituted alkenyl group; R4 represents a hydrogen atom, an optionally substituted alkyl group, or an optionally substituted alkenyl group, or R4 forms a double bond between the carbon atom to which R3 is bonded and the adjacent carbon atom to form a benzothiophene skeleton, or R3 and R4 are taken together to form a 5- to 8-membered spiro ring which may contain a hetero atom, e.g., oxygen, sulfur or nitrogen; and n represents an integer of 0 to 2, or a pharmaceutically acceptable salt thereof. The compound of formula (I) exhibits an inhibitory action on the oxidative modification of LDL and is useful as therapeutics of arteriosclerosis.

  由式(I)代表的化合物： 其中 R1 代表氢原子、低级烷基或酰基；R2 和 R3 可以相同或不同，各自代表氢原子、任选取代的烷基或任选取代的烯基；R4 代表氢原子、任选取代的烷基或任选取代的烯基，或 R4 在与 R3 键合的碳原子和相邻碳原子之间形成双键以形成苯并噻吩骨架，或 R3 和 R4 合在一起形成 5 至 8 元螺环，该螺环可包含杂原子，例如g.,氧、硫或氮；以及 n 代表 0 至 2 的整数、 或其药学上可接受的盐。式（I）化合物对低密度脂蛋白的氧化修饰具有抑制作用，可作为动脉硬化的治疗药物。
• Persistent Fluorescence of Perylene Dyes by Steric Inhibition of Aggregation
  作者：Heinz Langhals、Rami Ismael、Oktay Yürük

  DOI：10.1016/s0040-4020(00)00452-x

  日期：2000.7

  The control of the self-organisation of dye molecules in solution by bulky peripheral groups has been demonstrated. Consequently, fluorescent dyes could be prepared with a persistent fluorescence, even at very high concentrations because of a complete suppression of aggregation. Fluorescence quantum yields of unity were found. (C) 2000 Elsevier Science Ltd. All rights reserved.